That is necessary, due to the fact that the way a protein in the human body folds figures out if a pharmaceutical will be able to bind to that protein and work. To put it simply, we need to understand how these proteins fold if we want a drug to work. Historically, this has been a trial-and-error process (brownstone research). However now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're created to do. This was a breakthrough nearly nobody observed. However it's going to have extensive implications for curing illness. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, naturally, there will be plenty of investment chances in this area, too. Shifting topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (legacy report prediction). That stated, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be amazed if it drew back possibly significantly before going higher - longtime readers. I have actually been covering bitcoin for a very long time now. One of the first research study reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary suggestion, I titled my report "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time. We were mostly informing readers. But that's not the big concern anymore. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche business. Mass, Mutual is a trusted 170-year-old organization. So consider that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a big reason I'm bullish on it this year. black sea. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are numerous terrific private business on the edge of hitting the public markets And I've been working on a brand-new method for you to invest even prior to these business go public.
This chance has been building over the last few years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover all the information. Go right here to reserve your spot for totally free.
Emma Walsh here, handling editor of the Diary. Regular Journal readers understand that tech isn't our usual beat (jeff brown 2020 predictions). And when it concerns tech investing, we leave it to the professionals. The good news is, we have a number of such specialists in our Rolodex. Our associate Jeff Brown will recognize to our long time readers. He is among the most accomplished tech investing professionals we understand (genetic sequencing companies jeff brown). In truth, he had a number of triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take an appearance at the big picture and anticipate what's simply around the corner.
That includes things like 5G networks, biotech, expert system, and a lot more. These patterns are experiencing rapid growth and producing incredible chances for financiers. I wish to ensure all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see being available in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a subject I've been covering for years now. democratic republic. But in spite of what numerous readers might believe, this is a pattern that's just beginning. Although the COVID-19 pandemic interfered with supply chains last year, an excellent 250 million 5G-enabled gadgets were still sold.
And all of this ultimately caused Apple postponing the release of the 5G-enabled i, Phone 12 by two months (jeff brown top stock pick 2021). Losing two months of manufacturing and sales really affects the number of 5G devices are sold in the fiscal year. When you consider all of that, selling 250 million units is exceptional. More significantly, the delays triggered by the pandemic produced a lots of bottled-up need. Which need is now going to be pushed into 2021. In fact, I predict that more than 500 million 5G devices will be shipped in 2021 - last year. Which's not my only 5G forecast When I've discussed 5G in the past, I have actually explained its 3 various stages.
In Phase Two, 5G gadgets go on sale. 5G phones and other items start to reach consumers. And in Stage Three, 5G services begin to be offered (biotech stocks jeff brown). That's when we start to see applications running on 5G networks. Consider things like enormous multiplayer video games over a smart phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will start Phase Three by this summer. This begins something of a virtuous cycle: The majority of people don't really care about the innovation. But they will care if there are interesting applications that can only be accessed with a 5G phone.
That leads to more 5G apps being developed. In fact, 5G is going to open a suite of incredible applications: self-driving automobiles, the Web of Things, robotic surgery, and more. All of these innovations require 5G. The investment chances moving forward will be massive. Stepping away from 5G, the next crucial technology I foresee in 2021 is CRISPR hereditary editing. CRISPR represents "clustered regularly interspaced short palindromic repeat." It's a mouthful. However it is among the most exciting developments in biotechnology. At a high level, CRISPR is a technology that can edit our genetic makeup as if it were software.
The program can crash or not work correctly. CRISPR utilizes a comparable idea however with our genetic code. "Typos" in our genome can result in illness. CRISPR can remedy these "typos." For many years, CRISPR was mainly a specific niche innovation that wasn't well comprehended. And throughout that time, there were actually just three companies operating in this space. However things are changing. CRISPR is no longer simply theoretical. We're seeing actual results. We're treating illness and seeing that this innovation simply works. And as an outcome, a "2nd crop" of early-stage CRISPR companies is going public and providing amazing returns. This entire industry is efficiently a greenfield chance.
There's space for lots of companies to exist in this space. artificial intelligence. And there will be more. That's my prediction for CRISPR in 2021. I forecast that two or 3 more genetic modifying companies will hold their IPOs. Sticking with biotechnology, we are seeing fantastic things taking place at the merging of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its latest Alpha, Fold software can precisely anticipate the folding of a protein based solely on its amino acid sequence with 92. 4% precision. That is necessary since the method a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and be efficient.
Historically, this has been an experimental process. Today, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it much easier to produce drugs that do what they're developed to do. And here's my next forecast. I predict that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one but several drug therapies produced utilizing this innovation. This was one of those developments that practically no one discovered. However it's going to have extensive implications for treating disease. And, obviously, there will be plenty of financial investment chances in this area, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I would not be amazed if it drew back possibly significantly before going greater. I've been covering bitcoin for a long time now. One of the very first research study reports I ever released was on bitcoin - social media. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anyone who followed my suggestion. But at the time of that initial suggestion, I entitled my report, "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time.
But no one is asking that concern any longer. Now, we're seeing institutional money finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche business. biotech stock. Mass, Mutual is a 150-year-old institution. So think of that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more benefit forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and claims the details is up to date as of February 2021, however we could not individually verify this claim. Given Jeff Brown's past, he likely has a considerable net worth, but we can't hammer down an accurate figure at this moment. Brown is best understood for his sage-like capability to select winning technology stocks. He invested more than 25 years researching innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience gives him an outstanding viewpoint on the marketplace. He's constantly on the hunt for new opportunities, and he shares much of his finest picks in the Near Future Report.
That's high appreciation, however it's not ridiculously reasoned. Brown has an outstanding credibility as a stock-picker, and he effectively anticipated some of the greatest financial events of the past twenty years. Although he doesn't appear to launch his choices to the general public, the service's success is a direct indication of Brown's stock-picking prowess. Nobody on Wall Street gets it best each time, however Jeff Brown's accurate predictions have earned him legions of dedicated followers. That states a lot about his capability. The Near Future Report is released by Brownstone Research study, a popular monetary research publisher. Brownstone Research study provides numerous research services with a wide array of specializations - self-driving cars.
The company is likewise affiliated with Bonner & Partners, another well-respected research study publisher - jeff brown biotech stocks. On its website, Brownstone states its objective is to supply retail financiers with professional-grade research study: "For too long, the best investment research has actually not been available to individual financiers. It has actually been typically scheduled for investment banks, hedge funds, personal equity, and high-net-worth clients. second wave. The mission of Brownstone Research is to make that sort of proprietary research study readily available to any investors looking to gain an edge in the marketplaces. The goal is simple to provide distinct and profitable investment research study discovered nowhere else." -Brownstone Research website excerpt from the Jeff Brown is the founder of Brownstone Research study, and he also functions as the firm's Chief Investment Analyst.
With Brown directing the ship, Brownstone Research is a powerhouse publisher with lots to offer its clients. After years of consistent success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a family name throughout most of America. If you know even a little bit about the market, you understand that he has a reputation as a King Midas of sorts. biotech stocks. Everything he touches relies on gold! Jeff is well conscious of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big project.
In truth, Brown thinks S.A.V. jeff brown investment prediction. might be "the most significant pattern of the 2020s, and he's not alone. Have a look at these quotes from other popular S.A.V. bulls: Elon's next huge act will be weding two innovative innovations: synthetic intelligence and electric vehicles. Musk hopes the mix will assist him establish the very first fully-autonomous, self-driving automobiles ever. It's absolutely nothing except the vehicle market's Holy Grail. As you know, electrical lorries and self-driving vehicle stocks have actually been huge this year, but the Wall Street maker has actually been big on hype without much concrete outcome. Regardless of a drastic boost in competition over the previous few years, Brown still believes Musk has the very best chance of putting it all together.
tech could be the magic string that ties it all together. S.A.V. means Shared Autonomous Lorry, and it could be the future of transportation. Essentially, this technology would permit you to rent your car as a self-governing, self-driving taxi when you're not utilizing it. You simply leave the vehicle and press a button on an app that informs the car to "join the fleet." Next thing you know, you're unwinding on your sofa while your cars and truck shuttles ride-sharers around town. Best of all, you get to keep a substantial piece of the earnings. It sounds ridiculous, but it might be closed than you believe.